Intellectual Property India Publishes Patent Application for 'Pharmaceutical Compositions Of H1 Receptor Antagonists For Rectal Administration To Treat Inflammatory Bowel Diseases (IBD)' Filed by Pdfe Pharma Innovations - FZCO

MUMBAI, India, April 4 -- Intellectual Property India has published a patent application (202341065722 A) filed by Pdfe Pharma Innovations - FZCO, Bengaluru, Karnataka, on Sept. 29, 2023, for 'pharmaceutical compositions of h1 receptor antagonists for rectal administration to treat inflammatory bowel diseases (ibd).'

Inventor(s) include Fredrik Enqvist.

The application for the patent was published on April 4, under issue no. 14/2025.

According to the abstract released by the Intellectual Property India: "Pharmaceutical compositions of H1 receptor antagonists for rectal administration to treat Inflammatory Bowel Diseases (IBD) Abstract The present invention relates to pharmaceutical compositions for rectal administration, preferably suppo...